Bone marrow stromal cells transplantation for traumatic brain injury
Ma J,Zhang CG,Li Y
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.15.040
2007-01-01
Abstract:OBJECTIVE: To review the therapeutic effect of bone marrow stromal cells (BMSCs) in traumatic brain injury (TBI) treatment. DATA SOURCES: Using the key words of "bone marrow stromal cells (BMSCs),traumatic brain injury (TBI),cell transplantation", we searched the PUBMED database for related articles published from October 1996 to October 2006 in English. STUDY SELECTION: All Articles were selected firstly, and each citation of those articles was looked over. Inclusive criteria: articles must be related to the research about treatment of traumatic brain injury with BMSCs. Exclusive criteria: repetitive research or Meta analysis articles were excluded. DATA EXTRACTION: There were 138 articles related to BMSCs treating TBI, among which 31 met the inclusive criteria, including the biological characteristics of BMSCs, induction and differentiation in vitro, method of transplantation, the application of BMSCs in TBI and central nervous system and the functional mechanism. 107 excluded articles were with old or repetitive content. DATA SYNTHESIS: BMSCs, a group of non-hematopoietic stem cells, resided in bone marrow, which had good self-renewal and multi-differentiate capacity. BMSCs could be differentiated a variety of connective tissue cells in vitro, such as osteocytes, chondrocytes, tenocytes, adipocytes, nerve cells and smooth muscle cells etc., under distinct induced conditions. When injected directly into the brain parenchyma, the cerebrospinal fluid or the bloodstream, BMSCs could permeate the blood brain barrier (BBB) and survive for long time in central nervous system, migrate to the injured site. Though replacement of the injured cells and activation of endogenous repairing mechanism, BMSCs could ameliorate impaired neuronal function, promote neuroplasticity after TBI. Further study still should be done in following aspects: identifying specific molecular mark of BMSCs, isolating, purifying, homing and differentiation mechanism in vivo, molecular mechanism of promoting neuroplasticity after TBI. CONCLUSION: When injected directly into the brain parenchyma, the cerebrospinal fluid or the bloodstream, BMSCs can promote recovery of TBI. The therapeutic mechanism is concerned with replacement of the injured cells and activation of endogenous repairment. BMSCs transplantation is a promising therapy of TBI, though there are still some problems unresolved currently.